|
BCRX | Biocryst Pharmaceuticals Inc |
|
|
BCRX | Biocryst Pharmaceuticals Inc |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ -0.25 |
| Leverage | 186.89% |
| Market Cap | $ 1.6B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -8.8m |
| Margin | -1.64% |
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small molecule drugs. The company is headquartered in Durham, North Carolina.